Benzinga's Top Upgrades, Downgrades For January 23, 2018

Top Upgrades

  • Argus Research upgraded Amgen, Inc. AMGN from Hold to Buy. Amgen shares rose 0.15 percent to $192.62 in pre-market trading.
  • Wells Fargo upgraded Dollar General Corp. DG from Market Perform to Outperform. Dollar General rose 0.75 percent to $103.04 in pre-market trading.
  • Analysts at Credit Suisse upgraded Duke Energy Corp DUK from Neutral to Outperform. Duke Energy shares rose 0.32 percent to $77.20 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Crispr Therapeutics AG CRSP from Hold to Buy. CRISPR Therapeutics shares gained 7.82 percent to $36.39 in pre-market trading.
  • Analysts at Mizuho upgraded Exelon Corporation EXC from Underperform to Neutral. Exelon shares gained 0.92 percent to $38.40 in pre-market trading.
  • Analysts at Barclays upgraded Altice USA Inc ATUS from Equal-Weight to Overweigh. Altice USA shares rose 3.42 percent to $22.65 in pre-market trading.
  • Morgan Stanley upgraded NetApp Inc. NTAP from Underweight to Equal-Weight. NetApp shares gained 0.68 percent to close at $63.52 on Monday.
  • Analysts at KeyBanc upgraded Central Garden & Pet Co CENT from Sector Weight to Overweight. Central Garden shares rose 0.24 percent to close at $37.82 on Monday.
  • Stifel Nicolaus upgraded Axcelis Technologies Inc ACLS from Hold to Buy. Axcelis Technologies shares rose 2.5 percent to $26.65 in pre-market trading.
  • Piper Jaffray upgraded Triumph Bancorp Inc TBK from Neutral to Overweight. Triumph Bancorp shares rose 2.78 percent to close at $37.00 on Monday.


Top Downgrades

  • Analysts at Deutsche Bank downgraded Arista Networks Inc ANET from Buy to Hold. Arista shares fell 2.17 percent to $269.70 in pre-market trading.
  • Morgan Stanley downgraded HP Inc HPQ from Overweight to Equal-Weight. HP shares fell 1.05 percent to $23.60 in pre-market trading.
  • Keefe Bruyette & Woods downgraded Validus Holdings, Ltd. VR from Outperform to Market Perform. Validus shares climbed 44.03 percent to close at $67.29 on Monday.
  • Mizuho downgraded Southern Co SO from Buy to Neutral. Southern shares fell 0.43 percent to $43.85 in pre-market trading.
  • Barclays downgraded Sanofi SA (ADR) SNY from Equal-Weight to Underweight. Sanofi shares gained 1.23 percent to $43.73 in pre-market trading.
  • Morgan Stanley downgraded GoPro Inc GPRO from Equal-Weight to Underweight. GoPro shares dropped 7 percent to $5.86 in pre-market trading.
  • Macquarie downgraded Sprint Corp S from Neutral to Underperform. Sprint shares fell 0.94 percent to $5.27 in pre-market trading.
  • Analysts at SunTrust Robinson Humphrey downgraded Juno Therapeutics Inc JUNO from Buy to Hold. Juno Therapeutics shares fell 0.35 percent to $85.70 in pre-market trading.
  • DA Davidson downgraded NetApp Inc. NTAP from Buy to Neutral. NetApp shares rose 0.25 percent to $63.68 in pre-market trading.
  • Jefferies downgraded Bioverativ Inc BIVV from Buy to Hold. Bioverativ shares climbed 61.89 percent to close at $103.79 on Monday.


Top Initiations

  • Buckingham initiated coverage on Navistar International Corp NAV with a Neutral rating. The price target for Navistar is set to $48. Navistar shares closed at $44.75 on Monday.
  • DA Davidson initiated coverage on Jack Henry & Associates, Inc. JKHY with a Neutral rating. The price target for Jack Henry is set to $118. Jack Henry shares closed at $125.32 on Monday.
  • Deutsche Bank initiated coverage on Mobile Mini Inc MINI with a Hold rating. The price target for Jack Henry is set to $39. Mobile Mini shares closed at $36.90 on Monday.
  • Analysts at UBS initiated coverage on Lennox International Inc. LII with a Neutral rating. Lennox shares closed at $215.62 on Monday.
  • Analysts at Stifel Nicolaus initiated coverage on Simply Good Foods Co SMPL with a Buy rating. The price target for Simply Good Foods is set to $16. Simply Good Foods shares closed at $14.13 on Monday.
  • William Blair initiated coverage on Global Blood Therapeutics Inc GBT with an Outperform rating. The price target for Global Blood Therapeutics is set to $80. Global Blood Therapeutics shares closed at $56.35 on Monday.
  • UBS initiated coverage on 3M Co MMM with a Neutral rating. 3M shares closed at $247.30 on Monday.

Posted In: Building ProductsConstruction & Farm Machinery & Heavy TrucksIndustrialsInitiationstop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.